Dr. Casey Lee Cotant, MD

Dr. Cotant practices at Kootenai Health in Coeur D Alene, Idaho, part of Kootenai Health.

Dr. Cotant's NPI, 1427182781, was assigned on March 16, 2007. Dr. Cotant graduated from University of Utah School of Medicine in 2002. Dr. Cotant holds Idaho license M15124.

Dr. Cotant's primary practice is Kootenai Health, at 2003 Kootenai Health Way, Coeur D Alene, ID 83814 in Kootenai County. The practice phone is (208) 625-4000.

Dr. Cotant's primary practice is Kootenai Health in Coeur D Alene, Idaho, part of Kootenai Health. Dr. Cotant is also affiliated with Bonner General Health. The medical group on file is Kootenai Health. Dmand AI also links Dr. Cotant to 3 more hospitals, 3 dialysis centers, 1 hospital outpatient department and 1 medical group, each named with a free account. Dr. Cotant's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cotant practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Cotant's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Cotant is licensed in Idaho.

CMS data shows 1,774 Medicare services from Dr. Cotant across 10 procedure codes in 2024, for 394 Medicare patients. Medicare paid $126,591 for them.

CMS counts 394 Medicare patients who saw Dr. Cotant in 2024. The largest group is 75 to 84, with 177 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 12% are also on Medicaid. Their average risk score is 3.09, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cotant's median patient age at 76, with 48% women.

In 2024, Dr. Cotant wrote 2,527 Medicare Part D claims for 319 patients. 82% of them were for generic drugs. CMS names the drug for 2,205 of them, across 39 drugs with 11 or more claims each, at $592,553 in total drug cost. In 2023, CMS named 1,893 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Cotant for performance year 2024, reported through an alternative payment model (APM). Dr. Cotant accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cotant as offering telehealth.

Dmand AI links 6 papers to Dr. Cotant, published from 2011 to 2012. 2012 was the busiest year, with 2. Dr. Cotant's most frequent co-authors are Molly Ann Tilley, MD, Lorne Howar Blackbourne, MD and Todd Foster Michael Huzar, MD.

CMS Open Payments shows 5 general payments to Dr. Cotant from 2 drug and device companies from 2019 to 2024. Education make up the largest share, 100% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $125.

Dr. Cotant graduated from University of Utah School of Medicine in 2002.